ES550822A0 - Procedimiento para preparar esteroides sustituidos en posi- cion 10 - Google Patents
Procedimiento para preparar esteroides sustituidos en posi- cion 10Info
- Publication number
- ES550822A0 ES550822A0 ES550822A ES550822A ES550822A0 ES 550822 A0 ES550822 A0 ES 550822A0 ES 550822 A ES550822 A ES 550822A ES 550822 A ES550822 A ES 550822A ES 550822 A0 ES550822 A0 ES 550822A0
- Authority
- ES
- Spain
- Prior art keywords
- optionally substituted
- group
- image
- procedure
- carbon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0096—Alkynyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8500434A FR2576025B1 (fr) | 1985-01-14 | 1985-01-14 | Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8801509A1 ES8801509A1 (es) | 1988-01-16 |
ES550822A0 true ES550822A0 (es) | 1988-01-16 |
Family
ID=9315230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES550822A Expired ES8801509A1 (es) | 1985-01-14 | 1986-01-13 | Procedimiento para preparar esteroides sustituidos en posi- cion 10 |
Country Status (14)
Country | Link |
---|---|
US (1) | US4753932A (es) |
EP (1) | EP0188396B1 (es) |
JP (2) | JPH0772193B2 (es) |
KR (1) | KR930005993B1 (es) |
AT (1) | ATE45955T1 (es) |
AU (1) | AU582618B2 (es) |
CA (1) | CA1266466A (es) |
DE (1) | DE3665306D1 (es) |
DK (1) | DK169077B1 (es) |
ES (1) | ES8801509A1 (es) |
FR (1) | FR2576025B1 (es) |
HU (1) | HU196825B (es) |
IE (1) | IE59010B1 (es) |
ZA (1) | ZA86146B (es) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2639045B2 (fr) * | 1982-03-01 | 1994-07-29 | Roussel Uclaf | Nouveaux produits derives de la structure 3-ceto-delta-4,9-19-nor steroides et leur application comme medicaments |
FR2576025B1 (fr) * | 1985-01-14 | 1987-01-23 | Roussel Uclaf | Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant |
US5446178A (en) * | 1987-03-18 | 1995-08-29 | Schering Aktiengesellschaft | Process for preparing 19,11β-bridged steroids |
DE3708942A1 (de) * | 1987-03-18 | 1988-09-29 | Schering Ag | 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate |
US4910191A (en) * | 1988-06-28 | 1990-03-20 | Merrell Dow Pharmaceuticals Inc. | 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors |
DE3822770A1 (de) * | 1988-07-01 | 1990-01-04 | Schering Ag | 13-alkyl-11ss-phenylgonane |
DE3917274A1 (de) * | 1989-05-24 | 1990-11-29 | Schering Ag | 9(alpha)-hydroxy-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate |
FR2647452A1 (fr) * | 1989-05-24 | 1990-11-30 | Theramex | Nouveaux 19-nor steroides 6-methyles leurs procedes d'obtention, les compositions pharmaceutiques en renfermant et leur conversion en 19-nor pregnadienes 17-substitues |
CN1055929C (zh) * | 1993-09-20 | 2000-08-30 | 中国科学院上海有机化学研究所 | 三氟甲基甾体化合物及其制备方法 |
JP3862295B2 (ja) * | 1993-09-30 | 2006-12-27 | 独立行政法人理化学研究所 | 抗肥満剤 |
US5639598A (en) * | 1994-05-19 | 1997-06-17 | The Trustees Of The University Of Pennsylvania | Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions |
US5780220A (en) * | 1994-05-19 | 1998-07-14 | Trustees Of The University Of Pennsylvania | Methods and compositions for inhibiting HIV replication |
CN1055930C (zh) * | 1994-10-08 | 2000-08-30 | 中国科学院上海有机化学研究所 | 一种甾体烯醇多氟烃基磺酸酯化合物及其衍生物、用途和制备方法 |
CN1061983C (zh) * | 1996-11-29 | 2001-02-14 | 中国科学院上海有机化学研究所 | 一种4-三氟甲基-3-酮甾体化合物及其合成方法 |
CN1061987C (zh) * | 1997-08-28 | 2001-02-14 | 中国科学院上海有机化学研究所 | 6,10-亚甲基-19-降-甾体-4-烯-3-酮化合物及其合成 |
US6090798A (en) * | 1997-12-19 | 2000-07-18 | Alcon Laboratories, Inc. | Treatment of GLC1A glaucoma with glucocorticoid antagonists |
CN1064369C (zh) * | 1998-05-15 | 2001-04-11 | 中国科学院上海有机化学研究所 | 甾醇多氟芳酸酯、合成方法及其用途 |
CA2330611A1 (en) | 1998-05-22 | 1999-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
JP4676061B2 (ja) * | 1998-07-30 | 2011-04-27 | アボット・ラボラトリーズ | グルココルチコイド選択性薬剤 |
PL207610B1 (pl) * | 1999-04-30 | 2011-01-31 | Pfizer Prod Inc | Związki modulujące receptory glukokortykoidowe, ich zastosowanie do wytwarzania leku i środek farmaceutyczny |
US7713989B2 (en) | 2000-04-27 | 2010-05-11 | Dow Robert L | Glucocorticoid receptor modulators |
ATE303369T1 (de) | 2000-10-30 | 2005-09-15 | Pfizer Prod Inc | Glucocorticoid rezeptor modulatoren |
US8450379B2 (en) * | 2002-11-05 | 2013-05-28 | Corcept Therapeutics, Inc. | Methods for treating migraine |
JP2007537131A (ja) * | 2003-06-20 | 2007-12-20 | ヴァイラル・ジェノミックス・インコーポレーテッド | 抗ウイルス組成物および同一物を使用する方法 |
CN1221563C (zh) * | 2003-07-16 | 2005-10-05 | 中国科学院上海有机化学研究所 | 16-脱氢孕烯醇酮及其同类物的生产方法 |
CA2789262C (en) | 2005-04-28 | 2016-10-04 | Proteus Digital Health, Inc. | Pharma-informatics system |
WO2007035716A2 (en) | 2005-09-16 | 2007-03-29 | Raptor Pharmaceutical Inc. | Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof |
ES2581765T3 (es) | 2006-08-24 | 2016-09-07 | University Of Tennessee Research Foundation | Acilanilidas sustituidas y métodos de uso de las mismas |
NZ578638A (en) | 2007-02-02 | 2010-12-24 | Pfizer Prod Inc | Tricyclic compounds and their use as glucocorticoid receptor modulators |
PL2398500T3 (pl) | 2009-02-20 | 2019-09-30 | 2-Bbb Medicines B.V. | System dostarczania leków na bazie glutationu |
KR101741629B1 (ko) | 2009-05-06 | 2017-05-31 | 라보라토리 스킨 케어, 인크. | 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법 |
US11103514B2 (en) | 2010-05-26 | 2021-08-31 | Corcept Therapeutics, Inc. | Treatment of muscular dystrophy |
US10987334B2 (en) | 2012-07-13 | 2021-04-27 | University Of Tennessee Research Foundation | Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs) |
US10258596B2 (en) | 2012-07-13 | 2019-04-16 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
US10314807B2 (en) | 2012-07-13 | 2019-06-11 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
US9622992B2 (en) | 2012-07-13 | 2017-04-18 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
PT2872482T (pt) | 2012-07-13 | 2020-09-22 | Oncternal Therapeutics Inc | Método de tratamento de cancro de mama com modulador seletivo do recetor de andrógeno (sarm) |
US9969683B2 (en) | 2012-07-13 | 2018-05-15 | Gtx, Inc. | Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS) |
US9744149B2 (en) | 2012-07-13 | 2017-08-29 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
WO2016140867A1 (en) | 2015-03-02 | 2016-09-09 | Corcept Therapeutics, Inc. | Use of glucocorticoid receptor antagonist and somatostatin analogues to treat acth-secreting tumors |
AU2016243625B2 (en) | 2015-03-30 | 2020-09-10 | Corcept Therapeutics, Inc. | Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency |
EP3335043B1 (en) | 2015-08-13 | 2021-03-31 | Corcept Therapeutics, Inc. | Method for differentially diagnosing acth-dependent cushing's syndrome |
CA3011728A1 (en) | 2016-01-19 | 2017-07-27 | Corcept Therapeutics, Inc. | Differential diagnosis of ectopic cushing's syndrome |
CN107200770B (zh) * | 2016-03-18 | 2019-11-01 | 华东师范大学 | 特拉司酮合成中环氧异构体的高效分离和循环利用方法 |
EP3641780A4 (en) | 2017-06-20 | 2021-02-24 | Corcept Therapeutics, Inc. | TREATMENT METHODS OF NEURO-EPITHELIAL TUMORS USING SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
CA3205462A1 (en) | 2020-12-18 | 2022-06-23 | Instil Bio (Uk) Limited | Processing of tumor infiltrating lymphocytes |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1380411A (fr) * | 1962-02-24 | 1964-12-04 | Roussel Uclaf | Nouveau procédé de préparation de 10 beta-allyl-stéroïdes et produits utilisésdans ce procédé |
US3132138A (en) * | 1962-02-24 | 1964-05-05 | Roussel Uclaf | Preparation of 10beta-allyl steroids and intermediates |
FR2522328B1 (fr) * | 1982-03-01 | 1986-02-14 | Roussel Uclaf | Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments |
FR2569408B1 (fr) * | 1984-08-24 | 1986-10-03 | Roussel Uclaf | Nouveaux steroides substitues en position 10 par un radical comportant une double ou triple liaison, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant |
FR2576025B1 (fr) * | 1985-01-14 | 1987-01-23 | Roussel Uclaf | Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant |
-
1985
- 1985-01-14 FR FR8500434A patent/FR2576025B1/fr not_active Expired
-
1986
- 1986-01-08 ZA ZA86146A patent/ZA86146B/xx unknown
- 1986-01-13 DK DK013286A patent/DK169077B1/da not_active IP Right Cessation
- 1986-01-13 CA CA000499414A patent/CA1266466A/fr not_active Expired - Fee Related
- 1986-01-13 ES ES550822A patent/ES8801509A1/es not_active Expired
- 1986-01-13 HU HU86163A patent/HU196825B/hu not_active IP Right Cessation
- 1986-01-13 DE DE8686400057T patent/DE3665306D1/de not_active Expired
- 1986-01-13 EP EP86400057A patent/EP0188396B1/fr not_active Expired
- 1986-01-13 IE IE8386A patent/IE59010B1/en not_active IP Right Cessation
- 1986-01-13 AT AT86400057T patent/ATE45955T1/de not_active IP Right Cessation
- 1986-01-14 US US06/818,884 patent/US4753932A/en not_active Expired - Lifetime
- 1986-01-14 JP JP61004436A patent/JPH0772193B2/ja not_active Expired - Fee Related
- 1986-01-14 AU AU52283/86A patent/AU582618B2/en not_active Ceased
- 1986-01-14 KR KR1019860000163A patent/KR930005993B1/ko not_active IP Right Cessation
-
1994
- 1994-12-27 JP JP6336865A patent/JP2687209B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH07316185A (ja) | 1995-12-05 |
ES8801509A1 (es) | 1988-01-16 |
DE3665306D1 (en) | 1989-10-05 |
AU5228386A (en) | 1986-07-17 |
IE860083L (en) | 1986-07-14 |
FR2576025B1 (fr) | 1987-01-23 |
JPH0772193B2 (ja) | 1995-08-02 |
IE59010B1 (en) | 1993-12-03 |
FR2576025A1 (fr) | 1986-07-18 |
ATE45955T1 (de) | 1989-09-15 |
JPS61168029A (ja) | 1986-07-29 |
US4753932A (en) | 1988-06-28 |
DK169077B1 (da) | 1994-08-08 |
HUT41047A (en) | 1987-03-30 |
CA1266466A (fr) | 1990-03-06 |
JP2687209B2 (ja) | 1997-12-08 |
EP0188396A3 (en) | 1986-12-10 |
KR930005993B1 (ko) | 1993-07-01 |
EP0188396A2 (fr) | 1986-07-23 |
HU196825B (en) | 1989-01-30 |
DK13286D0 (da) | 1986-01-13 |
AU582618B2 (en) | 1989-04-06 |
EP0188396B1 (fr) | 1989-08-30 |
DK13286A (da) | 1986-07-15 |
KR860005832A (ko) | 1986-08-13 |
ZA86146B (en) | 1987-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES550822A0 (es) | Procedimiento para preparar esteroides sustituidos en posi- cion 10 | |
NL300392I1 (nl) | 11beta gesubstitueerde progesteronanaloga | |
FI880742A0 (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten, 7-asemassa substituoitujen 19-norsteroidien valmistamiseksi | |
SE7907224L (sv) | Delta 15 -steroider till anvendning i antikonceptionspreparat | |
FI842457A (fi) | 1-alkyl-androsta-1,4-dien-3,17-dioner, deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska produkter. | |
FI850151A0 (fi) | 6,6-etylen-15,16-metylen-3-oxo-17 -pregn-4-en-21,17-karbolaktoner, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat. | |
DK80487A (da) | Fedtemulsioner indeholdende prostaglandin i2'er | |
ES536649A0 (es) | Procedimiento para la preparacion de derivados de estrano y androstano | |
UA13378A (uk) | СПОСІБ ОДЕРЖАHHЯ ПОХІДHИХ 14, 17-beta-ЕТАHО-14-beta-ЕСТРАТРІЄHУ | |
ATE96444T1 (de) | 3-methylen-4-androsten-17-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate. | |
FI842397A (fi) | Foerfarande foer framstaellning av radioaktiva steroider och deras mellanprodukter, deras laemplighet foer paovisande av glukokortikoidreceptorer och bestaemmande av antalet bindningstaellen. | |
DK147684C (da) | Analogifremgangsmaade til fremstilling af 16alfa-ethyl-4,9,11-oestratrien-3-oner | |
EP0139907A3 (en) | Estrane derivatives | |
DK165879C (da) | 11beta-chlor-delta15-steroider til anvendelse i antikonceptionspraeparater | |
ES469513A1 (es) | Procedimiento para preparar nuevos derivados de pregn-4-eno. |